Industry News
Pharmaceutical Industry News
A Brukinsa regimen has delivered a…
A Brukinsa regimen has delivered a large progression-free survival benefit in what BeOne Medicines called a “new chemotherapy-free standard” in first-line mantle cell lymphoma.
Four months after Theravance…
Four months after Theravance Biopharma shut down its R&D unit, laid off half its staff and signaled it was up for sale, the Dublin-based company has entered into an agreement to be bought out by
Klick Health has struck its third…
Klick Health has struck its third takeover in 18 months, snapping up Oxford PharmaGenesis to expand its global reach and deepen its scientific expertise.
Sobi’s plan to introduce a…
Sobi’s plan to introduce a challenger to Amgen’s blockbuster gout drug Krystexxa has been put on hold by the FDA.
The FDA has approved Viridian…
The FDA has approved Viridian Therapeutics’ thyroid eye disease treatment, Lumvoa, initiating competition with Amgen’s blockbuster Tepezza, which is the only other therapy on the market for the eye-bulging autoimmune condition.
The agency spotted seven…
The agency spotted seven observations at Dr. Reddy's Bachupally, Hyderabad, biologics plant following a mid-June inspection.
The European Commission has kicked…
The European Commission has kicked off formal proceedings in an antitrust investigation against Sanofi. The probe surrounds the French drugmaker's marketing of its flu vaccine for at-risk seniors, Efluelda.
As Amgen prepares to defend…
As Amgen prepares to defend Tavneos’ market approval in the U.S., the company has received a bad omen overseas, with regulators recommending that the ANCA-associated vasculitis drug lose its authorization in the European Union after
In the past two weeks, CARsgen won…
In the past two weeks, CARsgen won the world's first approval for a solid tumor CAR-T, a behind-the-scenes look at Pfizer and Innovent Biologics' $10.5 billion cancer deal revealed a less-than-five-month sprint, Daiichi Sankyo's new
Eli Lilly is having a Total Recall…
Eli Lilly is having a Total Recall moment, using cutting-edge technology to bring real, undocumented memories to life as it looks to boost awareness of Alzheimer’s disease.
BeOne Medicines has extended its…
BeOne Medicines has extended its relationship with Blood Cancer United, committing $5 million over three years to support the nonprofit’s efforts to increase access to information and services.
Held just after the prestigious…
Held just after the prestigious Cannes Film Festival in southern France, the Cannes Lions Festival of Creativity has for years aimed to shine a spotlight on the world’s most creative brands and honor the best
Biogen is running a campaign aimed…
Biogen is running a campaign aimed at spreading awareness of the next-gen version of its spinal muscular atrophy therapy Spinraza.
Bayer has scored a key victory in…
Bayer has scored a key victory in its defense against Roundup lawsuits, as the U.S. Supreme Court has overturned a $1.25 million verdict from a jury in Missouri, which sided with a man who claimed
In a recent interview with Fierce,…
In a recent interview with Fierce, Fosun Pharma co-president, Xinli Wang, M.D., Ph.D., detailed how the company leveraged two recent deals to quickly build up its portfolio in Alzheimer’s disease as part of a multi-step
The FDA has accused Pinnacle…
The FDA has accused Pinnacle Biologics of creating videos that make it hard for healthcare professionals to “adequately process and comprehend the full indications” for a cancer drug.
With Merck KGaA’s former…
With Merck KGaA’s former electronics business lead Kai Beckmann now at the helm of the entire conglomerate, the new CEO is making his mark with a major outlay to support the company’s life sciences arm.
Jubilant HollisterStier, a CDMO…
Jubilant HollisterStier, a CDMO unit of India’s Jubilant Pharmova, earned an FDA warning letter after inspectors found its Montreal production plant lacked appropriate quality control systems.
Ionis has gained an FDA expansion…
Ionis has gained an FDA expansion for Tryngolza to become the first treatment specifically approved for severe hypertriglyceridemia. The nod will significantly increase the revenue-generating potential of the antisense oligonucleotide drug.
AstraZeneca has partnered with…
AstraZeneca has partnered with YMCA of the USA to increase awareness of cancer screening and early detection.